I. INTRODUCTION
. Thus if one can accelerate bone regeneration using osteogenic growth factors in a suitable manner, this regeneration technology will provide a new clinical procedure to promote bone repair and be a substitute for autogenous and allogenous bone grafts or biomaterial implants. 1) BMPs, with their potential to promote bone formation in vivo, have been used for bone regeneration to repair bone injuries and defects 2) . The current DNA technologies have enable the production of enough recombinant human BMPs for basic and applied research. BMP-2 and BMP-7 have already been clinically applied to accelerate bone regeneration, both in fracture healing and spinal fusion 3) . On the other hand, recombinant osteogenic protein 1 and partially purified osteogenic protein preparations have been shown to enhance the osseointegration around dental implants 4, 5) . Osteoblast differentiation and mineralization have been demonstrated on titanium, glass, and hydroxyapatite-coated implant surface 6, 7) . Using various methods, including immunocytochemical analysis and electron microscopy, no significant .
Covalent chemical strategies are often used to modify biomaterial surfaces with bioactive compounds. The rationale of these strategies has been supported by previous studies that showed that molecules covalently immobilized on surfaces are retained more dependably than molecules that are simply adsorbed 10, 11) . The use of biomimetic engineered surfaces have mainly used adhesive peptides. Relatively fewer studies have used BMP-derived peptides to determine if these peptides are osteogenic [11] [12] [13] [14] . We reported the initial results that rh BMP-7 derived peptides on glass coverslips enhanced peptide-induced mineralization 15) . However, additional studies are needed to support the initial results and to identify the molecular mechanism by which these peptides may mediate their events.
Therefore, the purpose of this study was to identify whether rh BMP-7 derived peptides on glass coverslips are able to support the osteoblast differentiation via the expression of extracellular matrix proteins such as, bone sialoprotein and osteocalcin in primary rat calvarial cells.
II. MATERIALS AND METHODS

rh BMP-7 peptides preparations
Thirteen overlapping peptides of 20 amino acids, each ( The resulting peptides (designated 1 through 13)
were used in the present study.
Cell culture of primary rat calvarial cells
Osteoblast-enriched cell preparations were obtained from SD rat 21-day fetal rat calvaria by sequential collagenase digestion in bone cell buffer. These cells were pooled and cultured in BGJb media with 10% FBS at 37℃ in a humidified atmosphere of 5% CO2 and 95% air.
Mineralization Assay
Primary rat calvarial cells were seeded in 12-well plate containing peptide-immobilized or control glass coverslips at an initial cell density of 10,000 cells per well after 14 and 21 days of culture, the cells were fixed in 4% formalin in sodium phosphate buffer and stained for calcium salts using the von Kossa method. Digital images of the fixed and stained cultures were acquired using a Sony CCD camera and a Nikon SMZ-U stereomicroscope at x 5 magnification.
Optimas image-processing software (Media Cybernetics, CA, U.S.A.) was used to detect and quantify darkly stained (mineralized) regions of the culture surface areas. One-way ANOVA was used to determine whether the culture condition affected the degree of mineralization.
Alkaline Phosphatase (ALP) Activity
The assay for ALP activity was carried out according to Bretaudiere and Spillman 16) . 
Total RNA extraction and RT-PCR analysis
Primary rat calvarial cells were plated into (Unit/100,000cells) 
IV. DISCUSSION
Improved understanding of cellular/molecular events which occur at the tissue-implant interface is contributing to a proactive approach of biomaterial design: the challenge of producing biomaterials which are engineered to elicit specific, desired responses from a patient's body 17, 18) . A biomaterial which has been engineered to enhance osteoblastic mineral deposition could, therefore, be of great clinical use.
BMPs include a large number of proteins belonging to the TFG-β superfamily and are characterized by their ability to induce bone and cartilage formation. Since BMPs can now be isolated and purified using recombinant technology, the effects of single BMPs can be evaluated in animal models 19) . The primary effect of BMP-7 on pluripotential cells that are capable of differentiating into osteoblasts appears to be its ability to commit the cells to an osteoblastic pathway 20, 21) . So, this study was designed to determine whether human BMP-7- 
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